Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
2.030
-0.080 (-3.79%)
At close: Dec 19, 2025, 4:00 PM EST
2.010
-0.020 (-0.99%)
After-hours: Dec 19, 2025, 5:26 PM EST
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $3.55 million as of December 19, 2025. Its market cap has decreased by -71.27% in one year.
Market Cap
3.55M
Enterprise Value
-2.26M
1-Year Change
-71.27%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has decreased from $47.95M to $3.55M, a decrease of -92.59%. That is a compound annual growth rate of -44.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 3.69M | -63.48% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | 47.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |